These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 15219702)

  • 1. Citalopram, a selective serotonin reuptake inhibitor augments harmaline-induced tremor in rats.
    Arshaduddin M; Al Kadasah S; Biary N; Al Deeb S; Al Moutaery K; Tariq M
    Behav Brain Res; 2004 Aug; 153(1):15-20. PubMed ID: 15219702
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exacerbation of harmaline-induced tremor by imipramine.
    Arshaduddin M; Kadasah S; Al Deeb S; Al Moutaery K; Tariq M
    Pharmacol Biochem Behav; 2005 May; 81(1):9-14. PubMed ID: 15894058
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Low-dose acute vanillin is beneficial against harmaline-induced tremors in rats.
    Abdulrahman AA; Faisal K; Meshref AA; Arshaduddin M
    Neurol Res; 2017 Mar; 39(3):264-270. PubMed ID: 28095756
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 2-deoxy-D-glucose attenuates harmaline induced tremors in rats.
    Tariq M; Arshaduddin M; Biary N; Al Moutaery K; Al Deeb S
    Brain Res; 2002 Aug; 945(2):212-8. PubMed ID: 12126883
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of acute caffeine on severity of harmaline induced tremor in rats.
    Al-Deeb S; Al-Moutaery K; Arshaduddin M; Biary N; Tariq M
    Neurosci Lett; 2002 Jun; 325(3):216-8. PubMed ID: 12044659
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of lidocaine on harmaline-induced tremors in the rat.
    Biary N; Arshaduddin M; Al Deeb S; Al Moutaery K; Tariq M
    Pharmacol Biochem Behav; 2000 Jan; 65(1):117-21. PubMed ID: 10638644
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 6-OHDA injections into A8-A9 dopaminergic neurons modelling early stages of Parkinson's disease increase the harmaline-induced tremor in rats.
    Kolasiewicz W; Kuter K; Berghauzen K; Nowak P; Schulze G; Ossowska K
    Brain Res; 2012 Oct; 1477():59-73. PubMed ID: 22902616
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Baclofen attenuates harmaline induced tremors in rats.
    Tariq M; Arshaduddin M; Biary N; Al Moutaery K; Al Deeb S
    Neurosci Lett; 2001 Oct; 312(2):79-82. PubMed ID: 11595339
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lesion of the cerebellar noradrenergic innervation enhances the harmaline-induced tremor in rats.
    Kolasiewicz W; Kuter K; Nowak P; Pastuszka A; Ossowska K
    Cerebellum; 2011 Jun; 10(2):267-80. PubMed ID: 21279489
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serotonin synthesis inhibition in olivo-cerebellar system attenuates harmaline-induced tremor in Swiss albino mice.
    Mehta H; Saravanan KS; Mohanakumar KP
    Behav Brain Res; 2003 Oct; 145(1-2):31-6. PubMed ID: 14529803
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The 5-HT1A receptor antagonist (S)-UH-301 augments the increase in extracellular concentrations of 5-HT in the frontal cortex produced by both acute and chronic treatment with citalopram.
    Arborelius L; Nomikos GG; Hertel P; Salmi P; Grillner P; Höök BB; Hacksell U; Svensson TH
    Naunyn Schmiedebergs Arch Pharmacol; 1996 May; 353(6):630-40. PubMed ID: 8738296
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Apomorphine enhances harmaline-induced tremor in rats.
    Ossowska K; Głowacka U; Kosmowska B; Wardas J
    Pharmacol Rep; 2015 Jun; 67(3):435-41. PubMed ID: 25933950
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Behavioral and neurochemical study on the mechanism of the anxiolytic effect of a selective serotonin reuptake inhibitor, a selective serotonin1A agonist and lithium carbonate].
    Muraki I
    Hokkaido Igaku Zasshi; 2001 Mar; 76(2):57-70. PubMed ID: 11344903
    [TBL] [Abstract][Full Text] [Related]  

  • 14. R-citalopram inhibits functional and 5-HTP-evoked behavioural responses to the SSRI, escitalopram.
    Sánchez C; Kreilgaard M
    Pharmacol Biochem Behav; 2004 Feb; 77(2):391-8. PubMed ID: 14751469
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Simple pharmacological test battery to assess efficacy and side effect profile of centrally acting muscle relaxant drugs.
    Farkas S; Berzsenyi P; Kárpáti E; Kocsis P; Tarnawa I
    J Pharmacol Toxicol Methods; 2005; 52(2):264-73. PubMed ID: 16125625
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of anxiety in the development of levodopa-induced dyskinesias in an animal model of Parkinson's disease, and the effect of chronic treatment with the selective serotonin reuptake inhibitor citalopram.
    Kuan WL; Zhao JW; Barker RA
    Psychopharmacology (Berl); 2008 Apr; 197(2):279-93. PubMed ID: 18157704
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Additive effect of rimonabant and citalopram on extracellular serotonin levels monitored with in vivo microdialysis in rat brain.
    Ortega JE; Gonzalez-Lira V; Horrillo I; Herrera-Marschitz M; Callado LF; Meana JJ
    Eur J Pharmacol; 2013 Jun; 709(1-3):13-9. PubMed ID: 23562616
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Citalopram, a serotonin reuptake inhibitor, and brain ischemia in SHR.
    Nagao T; Ibayashi S; Sadoshima S; Izumi J; Fujishima M
    Brain Res Bull; 1995; 38(1):49-52. PubMed ID: 7552375
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Mechanisms of action of antidepressants: new data from Escitalopram].
    Fabre V; Hamon M
    Encephale; 2003; 29(3 Pt 1):259-65. PubMed ID: 12876551
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of citalopram on brain serotonin release in experimental hepatic encephalopathy: implications for thymoleptic drug safety in liver insufficiency.
    Bergqvist PB; Wikell C; Hjorth S; Apelqvist G; Bengtsson F
    Clin Neuropharmacol; 1997 Dec; 20(6):511-22. PubMed ID: 9403225
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.